Extracellular vesicles and cancer stemness in hepatocellular carcinoma – is there a link?
Authors:
Open Access
- 27 February 2024
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 15, 1368898
Abstract
Hepatocellular carcinoma (HCC) is a highly aggressive malignancy, with high recurrence rates and notorious resistance to conventional chemotherapy. Cancer stemness refers to the stem-cell-like phenotype of cancer cells and has been recognized to play important roles in different aspects of hepatocarcinogenesis. Small extracellular vesicles (sEVs) are small membranous particles secreted by cells that can transfer bioactive molecules, such as nucleic acids, proteins, lipids, and metabolites, to neighboring or distant cells. Recent studies have highlighted the role of sEVs in modulating different aspects of the cancer stemness properties of HCC. Furthermore, sEVs derived from diverse cellular sources, such as cancer cells, stromal cells, and immune cells, contribute to the maintenance of the cancer stemness phenotype in HCC. Through cargo transfer, specific signaling pathways are activated within the recipient cells, thus promoting the stemness properties. Additionally, sEVs can govern the secretion of growth factors from non-cancer cells to further maintain their stemness features. Clinically, plasma sEVs may hold promise as potential biomarkers for HCC diagnosis and treatment prediction. Understanding the underlying mechanisms by which sEVs promote cancer stemness in HCC is crucial, as targeting sEV-mediated communication may offer novel strategies in treatment and improve patient outcome.Keywords
This publication has 115 references indexed in Scilit:
- HCC EV ECG score: An extracellular vesicle‐based protein assay for detection of early‐stage hepatocellular carcinomaHepatology, 2023
- Loss of exosomal miR ‐34c‐5p in cancer‐associated fibroblast for the maintenance of stem‐like phenotypes of laryngeal cancer cellsHead & Neck, 2022
- Conscription of Immune Cells by Light‐Activatable Silencing NK‐Derived Exosome (LASNEO) for Synergetic Tumor EradicationAdvanced Science, 2022
- Knockdown of ST6Gal‐I expression in human hepatocellular carcinoma cells inhibits their exosome‐mediated proliferation‐ and migration‐promoting effectsIUBMB Life, 2021
- Hypoxic colorectal cancer‐derived extracellular vesicles deliver microRNA‐361‐3p to facilitate cell proliferation by targeting TRAF3 via the noncanonical NF‐κB pathwaysClinical and Translational Medicine, 2021
- Transfer of metastatic traits via miR‐200c in extracellular vesicles derived from colorectal cancer stem cells is inhibited by atractylenolide IClinical and Translational Medicine, 2020
- The exosome encapsulated microRNAs as circulating diagnostic marker for hepatocellular carcinoma with low alpha‐fetoproteinInternational Journal of Cancer, 2020
- Downregulation of serum exosomal miR‐320d predicts poor prognosis in hepatocellular carcinomaJournal of Clinical Laboratory Analysis, 2020
- miR‐125a/b inhibits tumor‐associated macrophages mediated in cancer stem cells of hepatocellular carcinoma by targeting CD90Journal of Cellular Biochemistry, 2018
- Serum exosomal microRNAs combined with alpha‐fetoprotein as diagnostic markers of hepatocellular carcinomaCancer Medicine, 2018